Biohaven Ltd. (NYSE:BHVN) has announced major breakthroughs with its novel precision immunology therapies, BHV-1400 and ...

Researchers have developed a first-of-its-kind wearable tech that quickly, simply, and non-invasively tests for important ...

In Nature Communications the Korea Food Research Institute (KFRI) has released results on the growth regulation mechanisms of ...

Names like idarucizumab, levetiracetam and ustekinumab may look like words from Greek or Norse mythology, but they're chosen ...

Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...

Curious about mushroom supplements? Here’s what they do, what the science says, and how to know if they’re right for ...

Hormel Foods recalled 256,000 pounds of canned beef stew due to potential contamination with wood fragments. ( CBS News) ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...

The region that differs between the two splice forms accounts for their distinct ... thereby rendering the antibody inactive. Nevertheless, IgE can exert its functions through FcεRI at a lower ...

Under the deal, announced on May 20, Pfizer gains the opportunity to develop and sell the SSGJ-707 drug in markets outside of ...

Is an elite New Orleans charter school required to educate a 9-year-old boy with profound disabilities? A judge will decide.